Novus Showcased by Cannabis Business Times

Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

/UCW/ MIAMI, FL – Novus Acquisition and Development, Corp. (OTC PINK: NDEV), through its wholly-owned subsidiary, WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, annuity and accident and the nation’s first carrier/aggregator offering a cannabis health plan. NDEV today announced a featured cover article in Cannabis Business Times publication.

The article can be read here: 

Cannabis Business Times (CBT) is a leading cannabis industry publication that focuses accelerated success of the legal cannabis cultivators, manufacturers, dispensaries, and patient advocacy. CBT provides actionable intelligence in all aspects of the industry, from legislation, regulation, and compliance news to analysis of industry trends, as well as expert advice on cultivation, marketing, financial topics, legal issues, and more.

CBT focuses strictly on the business of legal cannabis for medical and recreational use and aims to provide timely information – through its website, e-newsletter, mobile app, print magazine and annual cultivation conference – to help the reader make timely, informed decisions to help them run their businesses better and more profitably.

About Novus

Novus Acquisition & Development Corp. (NDEV), through its subsidiary WCIG Insurance, provides health insurance and related insurance solutions within the wellness and medical marijuana industries in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business such as, health, property & casualty, life, accident and fixed annuities.

Novus medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on these press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. Once a push notification is competed the transaction is solely between the state-licensed dispensary and the registered patient.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws, allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to Novus Medical Group. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

– For more information, please visit: http://www.getnovusnow.comhttps://www.otcmarkets.com/stock/NDEV/filings – Learn How Insurance Companies Are Evaluated: http://bit.ly/2ddIYva

Forward-Looking Statements

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Novus Medical Group disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

Corporate:
Chairman and CEO
Frank Labrozzi
frank@ndev.biz
855-228-7355

Investors:
Hayden IR
hart@haydenir.com
917-658-7878

SOURCE: Novus Acquisition and Development

Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail
, ,

Stock Ticker

  • Loading stock data...